NCT03882463View on ClinicalTrials.gov

Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children With Type 1 Diabetes Treated With Insulin Pump

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

April 18, 2021

Study Completion Date

December 31, 2021

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Continuous glucose monitoring with the stop insulin pump function

"Children with type 1 diabetes using insulin pump and continuous glucose monitoring without the stop insulin pump functionare then using the predictive system for stopping before hypoglycaemia medtronic Minimed with SmartGuard technology."

Trial Locations (1)

51092

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT03882463 - Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children With Type 1 Diabetes Treated With Insulin Pump | Biotech Hunter | Biotech Hunter